The Queen, on the Prosecution of Giovanni Giacinto Achilli V John Henry Newman for Criminal Libel, Court of Queen's Bench, Westminister [sic] 1851-1853
Northern Virginia Foot & Ankle Associates 8221 Old Courthouse Rd STE 102, Vienna, VA 22182 7037341311 (phone), 7037349090 (fax)
Conditions:
Hallux Valgus Plantar Fascitis Tinea Pedis
Languages:
English Spanish
Description:
Dr. Smith works in Vienna, VA and 1 other location and specializes in Podiatric Medicine and Orthopaedic Surgery. Dr. Smith is affiliated with Laurel Regional Hospital and Virginia Hospital Center.
An ophthalmic solution comprising: 0. 01 to 5 weight percent imidazole: 0. 01 to 30 weight percent hydrogen peroxide and the balance water which can further comprisie 0. 01 to 2 weight percent of a buffer adjusted so the pH of the formulation is between 5. 5 to 8. 5.
The present invention relates to improved ophthalmic solutions that employ allantoin in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions.
An ophthalmic solutions that are broad ranged and effective in low concentrations relative to state of the art systems. In particular it has been found that ophthalmic solutions comprising 0. 00001 to about 1. 0 percent by weight of a nucleotide, a nucleoside or a purine or pyrimidine base; 0. 00001 to about 0. 05 percent by weight a cationic, polymeric preservative display an effective preservative capacity, and an increased capacity over state-of-the-art preservative systems.
Ophthalmic And Contact Lens Solutions Comprising Imidazole
The present invention relates to contact lens solutions employing imidazole as an additive. Lenses treated with these solutions have improved resistance to protein and other polymeric depositions. The addition of imidazole to the solutions decreases the denaturalization of proteins during the cleaning cycles, and coats treated lenses to decrease the number of active binding sites.
Francis X Smith - Salem NH, US John Randall Tracey - Salem NH, US
Assignee:
FXS Ventures, LLC - Salem NH
International Classification:
A61K 31/74 A61K 47/00 B01D 12/00
US Classification:
516204, 134901, 424 7804, 510112, 514786, 514839
Abstract:
An ophthalmic solution comprising a polyethoxylated glyceride in the range of 0. 001 to about 10 percent by weight and a buffer agent. These solutions impart surprising comfort and wearability to contact lenses. At the same time the solutions provide good preservative capacity and do not increase protein deposit.
Ophthalmic And Contact Lens Solutions Containing Peptides As Preservative
Francis X. Smith - Salem NH, US Kathryn S. Crawford - Andover MA, US
International Classification:
A61K 38/08 A61L 12/14
US Classification:
514 215, 424427, 424429, 514839, 530327
Abstract:
A contact lens solution comprising 0. 001 to 10 weight percent or a preservative enhancer chosen from the group consisting of: D4E1, D2A21, and P-113; and at least 0. 0001 weight percent of a preservative, and where the concentration of chloride in said solution is less than 0. 2 percent by weight.
Francis X. Smith - Salem NH, US John Randall Tracey - Salem NH, US
International Classification:
A61K 31/74 A61K 47/00 B01D 12/00
US Classification:
516204, 134901, 424 7804, 510112, 514786, 514839
Abstract:
An ophthalmic solution comprising a polyethoxylated glyceride in the range of 0. 001 to about 10 percent by weight and a buffer agent. These solutions impart surprising comfort and wearability to contact lenses. At the same time the solutions provide good preservative capacity and do not increase protein deposit.
Ophthalmic And Contact Lens Solutions Using Low Molecular Weight Amines
Mar 2009 to 2000 Senior Manufacturing Technician IAbbott Laboratories Worcester, MA Dec 2007 to Mar 2009 Senior Manufacturing Technician IAlexion Pharmaceuticals, Inc Smithfield, RI Feb 2007 to Dec 2007 Manufacturing Associate IIIBioVest International Worcester, MA Feb 2005 to Feb 2007 Purification Associate IIAltran Corporation Boston, MA Jun 2004 to Feb 2005 Laboratory TechnicianCetek Marlborough, MA Jan 2001 to Jun 2004 Instrument Operator III
Education:
Bridgewater State College Bridgewater, MA 1991 to 1994 BA in Biology
Name / Title
Company / Classification
Phones & Addresses
Francis Smith President
Bio-Concept Laboratories, Inc. Product Development & Marketing
President & CEO at Bio Concept Laboratories Past: Manager, Pharmaceutical Development at Telor Ophthalmic Pharmaceuticals, Manager... Received Ph.D. in Biochemistry from the University of Massachusetts, Lowell. Hold a M.S. in Chemistry from the Rochester Institute of Technology and a B.S. in... Received Ph.D. in Biochemistry from the University of Massachusetts, Lowell. Hold a M.S. in Chemistry from the Rochester Institute of Technology and a B.S. in Medicinal Chemistry from SUNY at Buffalo. Have over 40 U.S. Patents and is an author on 13 scientific publications and abstracts. Over 35...
Over 15 years of recruitment and staffing experience, with expertise in developing and delivering high-volume staffing programs to wide variety of... Over 15 years of recruitment and staffing experience, with expertise in developing and delivering high-volume staffing programs to wide variety of organizations. Also possess strong experience in executing recruitment initiatives to fill various professional and managerial positions in the...